Association of the Three Common SNPs of Cyclooxygenase-2 Gene (rs20417, rs689466, and rs5275) with the Susceptibility of Breast Cancer: An Updated Meta-Analysis Involving 34,590 Subjects

Several single nucleotide polymorphisms have been identified in cyclooxygenase-2 (COX-2) genes (e.g., −765 G>C (rs20417), −1195G>A (rs689466), and 8473 C>T (rs5275)). The association of these SNPs with the risk of different cancer types is still controversial. This study aims to evaluate the correlation between these SNPs and breast cancer risk in different ethnic groups. We have searched PubMed, Web of Knowledge, and Embase for relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to estimate the strength of the associations. A total of 13 studies (15,330 cases and 19,260 controls) were eligible for meta-analysis. This meta-analysis showed that COX-2 rs20417 polymorphism was correlated with an increased risk of breast cancer in Caucasians, while rs689466 was associated with a decreased risk of breast cancer in Caucasians. The rs5275 polymorphism had no association with breast cancer risk.

• Publication year

  2014

• Venue

  Disease Markers

• Publication date

  2014-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2014/484729PMID 25214704PMCID 4151597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women

  2014influential reference
• Cyclooxygenase-2 169 C > G and 8473 T > C gene polymorphisms and prostaglandin E 2 level in breast cancer : A case – control study

  2013cited by this paper
• Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Regulation of Immune Responses by Prostaglandin E2

  2012cited by this paper
• Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

  2012cited by this paper
• The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.

  2011cited by this paper
• Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study

  2011cited by this paper
• PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

  2010influential reference
• Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis

  2010influential reference
• The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies

  2010cited by this paper
• Polymorphisms in regulatory regions of Cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study

  2010influential reference
• Common Polymorphisms in the Prostaglandin Pathway Genes and Their Association with Breast Cancer Susceptibility and Survival

  2009cited by this paper
• A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.

  2009influential reference
• −765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case–control studies

  2009cited by this paper
• The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

  2009cited by this paper
• Reprint of Breast cancer: hormones and other risk factors

  2008cited by this paper
• A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study

  2007cited by this paper
• Functional Polymorphisms in the Cyclooxygenase 2 (COX-2) Gene and Risk of Breast Cancer in a Chinese Population

  2007influential reference
• Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk

  2006cited by this paper
• The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.

  2006cited by this paper
• Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

  2006cited by this paper
• Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma.

  2004cited by this paper
• Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival

  2003cited by this paper
• Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

  2002cited by this paper
• A comprehensive review of genetic association studies

  2002cited by this paper
• Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

  2002cited by this paper
• The 3′-Untranslated Region of Murine Cyclooxygenase-2 Contains Multiple Regulatory Elements That Alter Message Stability and Translational Efficiency*

  2001cited by this paper
• Breast cancer: hormones and other risk factors.

  2001cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• Cyclooxygenases 1 and 2.

  1998cited by this paper
• Breast cancer risk and environmental exposures.

  1997cited by this paper
• Cancer statistics

  1989cited by this paper

• The role of COX-2 and its use as a therapeutic target in IBD and related colorectal cancer.

  2025cites this paper
• Association of the PTGS2 8473T>C polymorphism with depression and nausea in Iranian migraineurs

  2025cites this paper
• Single Nucleotides Polymorphisms in COX2 Gene and their Association with Signs and Symptoms of Teething – A Pilot Study

  2023cites this paper
• Genetic Variants in COX2 and ALOX Genes and Breast Cancer Risk in White and Black Women

  2021cites this paper
• Association between COX‐2 and 15‐PGDH polymorphisms and SLE susceptibility

  2020cites this paper
• Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region

  2019cites this paper
• Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population

  2019cites this paper
• Use of Common Genetic Variants (Single Nucleotide Variants) to Predict Risk of Nonfamilial Breast Cancer

  2018cites this paper
• Cyclooxygenase-2 (COX-2) polymorphism rs689466 may contribute to the increased susceptibility to post-traumatic osteomyelitis in Chinese population

  2017cites this paper
• Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism

  2017cites this paper
• COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data

  2016cites this paper
• Pharmacogenomics of cyclooxygenases.

  2015cites this paper
• Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies

  2015cites this paper
• Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.

  2015cites this paper
• Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.

  2015cites this paper
• Cyclooxygenase-2–1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls

  2015cites this paper
• Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia

  2015cites this paper
• Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case–control studies

  2014influential citation
• Medical Policy Use of Common Genetic Variants to Predict Risk of Nonfamilial Breast Cancer

  2013cites this paper
• COX-2-8473 T>C gene variant (rs5275) is associated with depression and nausea in migraineurs by increasing in�ammation through MyD88/MAP2K3/COX-2

  year unknowncites this paper